Histone deacetylase (HDAC) inhibitors are an emerging class of therapeutic agents that induce tumor cell cytostasis, differentiation and apoptosis in variou
The qualification of nephrotoxicity biomarkers in preclinical and clinical laboratories in academic, government or industrial organizations requires intensi